186 related articles for article (PubMed ID: 38745647)
1. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
[TBL] [Abstract][Full Text] [Related]
2. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X
Front Immunol; 2022; 13():845988. PubMed ID: 35320936
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease.
Ren FP; Chen Q; Yao SS; Feng L; Xue XY; Zhao WC; Wang D; Zhao ZL; Gu SW; Li T; Shen YW; Gao L; Zang XL; Bao XY; Tong ZH
BMC Pulm Med; 2023 Oct; 23(1):411. PubMed ID: 37898737
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
Zanatta E; Cocconcelli E; Castelli G; Giraudo C; Fraia AS; De Zorzi E; Gatto M; Ienna L; Treppo E; Malandrino D; Cereser L; Emmi G; Giannelli F; Bellani S; Martini A; Moccaldi B; Ghirardello A; Avouac J; Quartuccio L; Allanore Y; Doria A; Spagnolo P; Balestro E; Iaccarino L
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37541742
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
[TBL] [Abstract][Full Text] [Related]
6. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis.
Jin Q; Fu L; Yang H; Chen X; Lin S; Huang Z; Gao B; Tian X; Jiang W; Shu X; Lu X; Wang G; Peng Q
J Intern Med; 2023 Apr; 293(4):494-507. PubMed ID: 36682032
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
8. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
Front Immunol; 2022; 13():879266. PubMed ID: 35603153
[TBL] [Abstract][Full Text] [Related]
9. Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis.
So J; So H; Wong VT; Ho R; Wu TY; Wong PC; Tam LH; Ho C; Lam TT; Chung YK; Li WL; To CH; Lau CS; Mok CC; Tam LS
Rheumatology (Oxford); 2022 Nov; 61(11):4437-4444. PubMed ID: 35157042
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
[TBL] [Abstract][Full Text] [Related]
11. Hypouricemia as a novel predictor of mortality in anti-MDA5 positive dermatomyositis patients with ILD: A retrospective cohort study.
Liu H; Chen B; Guo Y; Liu H; Ran J; Liu R; Yin G; Xie Q
Respir Med; 2024 Feb; 222():107530. PubMed ID: 38228214
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for progressive fibrosing interstitial lung disease in anti-synthetase syndrome.
Zhao Y; Zhang C; Su H; Yin X; Liu X; Hou H; Wang G; Li D; Zhang N; Wei W
Int J Rheum Dis; 2023 May; 26(5):885-894. PubMed ID: 36938815
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognostic factors of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated interstitial lung disease].
Zou RY; Zhao Q; Tian YQ; Yan X; Qiu XH; Gao YJ; Liu Y; Huang M; Cao M; Dai JH; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):781-790. PubMed ID: 37536988
[No Abstract] [Full Text] [Related]
14. Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
Li M; Zhao X; Liu B; Zhao Y; Li X; Ma Z; Yang Q
Front Immunol; 2023; 14():1209282. PubMed ID: 37691917
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis.
Li Y; Li Y; Wu J; Miao M; Gao X; Cai W; Shao M; Zhang X; Xu Y; Cong L; He J; Sun X
J Immunol Res; 2020; 2020():2024869. PubMed ID: 33299896
[TBL] [Abstract][Full Text] [Related]
16. Progression prediction in idiopathic inflammatory myopathy-associated interstitial lung disease: a combination of initial high attenuation areas and anti-melanoma differentiation-associated gene 5-positive.
Fang X; Zou L; Zhao H; Liu B
Clin Exp Rheumatol; 2024 Feb; 42(2):253-261. PubMed ID: 38293996
[TBL] [Abstract][Full Text] [Related]
17. MDA5 expression is associated with TGF-β-induced fibrosis: potential mechanism of interstitial lung disease in anti-MDA5 dermatomyositis.
Shen N; Zhou X; Jin X; Lu C; Hu X; Zhang Y; Jiang Y; Xu Q; Xu X; Liu M; Lu L; Han Y
Rheumatology (Oxford); 2022 Dec; 62(1):373-383. PubMed ID: 35412608
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum B-cell activator factor levels predict rapid progressive interstitial lung disease in anti-melanoma differentiation associated protein 5 antibody positive dermatomyositis.
Shi Y; You H; Liu C; Qiu Y; Lv C; Zhu Y; Xu L; Wang F; Zhang M; Tan W
Orphanet J Rare Dis; 2024 Apr; 19(1):170. PubMed ID: 38637830
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis.
Zuo Y; Ye L; Liu M; Li S; Liu W; Chen F; Lu X; Gordon P; Wang G; Shu X
Rheumatology (Oxford); 2020 Oct; 59(10):2829-2837. PubMed ID: 32065646
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis.
Gui X; Ma M; Ding J; Shi S; Xin X; Qiu X; Zhang Y; Qiu Y; Cao M; Huang M; Cao M; Dai J; Cai H; Xiao Y
Rheumatology (Oxford); 2021 Aug; 60(8):3913-3922. PubMed ID: 33501503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
